Literature DB >> 8545103

Functional hierarchy of c-kit and c-fms in intramarrow production of CFU-M.

T Sudo1, S Nishikawa, M Ogawa, H Kataoka, N Ohno, A Izawa, S Hayashi, S Nishikawa.   

Abstract

Whereas the molecular natures of M-CSF/CSF-1 and its receptor c-fms are well characterized, its actual role in the intramarrow hematopoiesis remains obscure. This is because disruption of this signaling pathway results in the osteopetrosis mouse that lacks the bone cavity for hematopoiesis. To elucidate the role of c-fms in intramarrow hematopoiesis, we produced an antagonistic monoclonal antibody to murine c-fms and investigated its expression and function in the normal bone marrow. c-fms+ cells were detected both in mature and immature hematopoietic cells. Morphologically, c-kit+c-fms-, c-kit+c-fms+ and c-kit-c-fms+ cells were medium sized blasts, large promyelocytes with azurophilic granules and mature monocytes respectively. CFU-M was 10-fold more enriched in the c-kit+c-fms- than c-kit+c-fms+ fraction. Moreover, injection of the anti c-fms antibody had no effect on the production of CFU-M in the bone marrow, while anti-c-kit mAb could deplete them. As c-kit+c-fms+ cells were readily generated in the culture of c-kit+c-fms- cells, most of the CFU-M in the bone marrow are, in fact, c-fms- cells that differentiate into c-fms+ upon culture. These observations indicate a clear functional hierarchy of c-kit and c-fms in the bone marrow. Namely, c-kit plays the primary role in the production and maintenance of CFU-M, while c-fms, though it co-expressed with c-kit and functions as the growth receptor for M-CSF in the culture, has only a minimum role in the proliferation of c-fms+ cells in the bone marrow.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8545103

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  53 in total

Review 1.  Studying the mononuclear phagocyte system in the molecular age.

Authors:  Andrew Chow; Brian D Brown; Miriam Merad
Journal:  Nat Rev Immunol       Date:  2011-10-25       Impact factor: 53.106

2.  Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells.

Authors:  Suwen Wei; Sayan Nandi; Violeta Chitu; Yee-Guide Yeung; Wenfeng Yu; Minmei Huang; Lewis T Williams; Haishan Lin; E Richard Stanley
Journal:  J Leukoc Biol       Date:  2010-05-26       Impact factor: 4.962

3.  Intestinal Monocyte-Derived Macrophages Control Commensal-Specific Th17 Responses.

Authors:  Casandra Panea; Adam M Farkas; Yoshiyuki Goto; Shahla Abdollahi-Roodsaz; Carolyn Lee; Balázs Koscsó; Kavitha Gowda; Tobias M Hohl; Milena Bogunovic; Ivaylo I Ivanov
Journal:  Cell Rep       Date:  2015-08-13       Impact factor: 9.423

4.  M-CSF mediates TNF-induced inflammatory osteolysis.

Authors:  Hideki Kitaura; Ping Zhou; Hyun-Ju Kim; Deborah V Novack; F Patrick Ross; Steven L Teitelbaum
Journal:  J Clin Invest       Date:  2005-11-17       Impact factor: 14.808

5.  The EGF/CSF-1 paracrine invasion loop can be triggered by heregulin beta1 and CXCL12.

Authors:  Lorena Hernandez; Tatiana Smirnova; Dmitriy Kedrin; Jeffrey Wyckoff; Liyin Zhu; E Richard Stanley; Dianne Cox; William J Muller; Jeffrey W Pollard; Nico Van Rooijen; Jeffrey E Segall
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

6.  Sirtuin 1 inhibits TNF-α-mediated osteoclastogenesis of bone marrow-derived macrophages through both ROS generation and TRPV1 activation.

Authors:  Shu Yan; Lujie Miao; Yahua Lu; Liangzhi Wang
Journal:  Mol Cell Biochem       Date:  2018-11-20       Impact factor: 3.396

7.  Transcription factor complex formation and chromatin fine structure alterations at the murine c-fms (CSF-1 receptor) locus during maturation of myeloid precursor cells.

Authors:  Hiromi Tagoh; Roy Himes; Deborah Clarke; Pieter J M Leenen; Arthur D Riggs; David Hume; Constanze Bonifer
Journal:  Genes Dev       Date:  2002-07-01       Impact factor: 11.361

8.  Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor.

Authors:  Antonia Patsialou; Jeffrey Wyckoff; Yarong Wang; Sumanta Goswami; E Richard Stanley; John S Condeelis
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

9.  GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells.

Authors:  Melanie Greter; Julie Helft; Andrew Chow; Daigo Hashimoto; Arthur Mortha; Judith Agudo-Cantero; Milena Bogunovic; Emmanuel L Gautier; Jennifer Miller; Marylene Leboeuf; Geming Lu; Costica Aloman; Brian D Brown; Jeffrey W Pollard; Huabao Xiong; Gwendalyn J Randolph; Jerry E Chipuk; Paul S Frenette; Miriam Merad
Journal:  Immunity       Date:  2012-06-29       Impact factor: 31.745

10.  M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis.

Authors:  Yoshiaki Kubota; Keiyo Takubo; Takatsune Shimizu; Hiroaki Ohno; Kazuo Kishi; Masabumi Shibuya; Hideyuki Saya; Toshio Suda
Journal:  J Exp Med       Date:  2009-04-27       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.